TrialInternational journal of hematology2011

Nilotinib as frontline therapy for patients with newly diagnosed Ph+ chronic myeloid leukemia in chronic phase: results from the Japanese subgroup of ENESTnd.

Hirohisa Nakamae et al.PubMed ↗Publisher ↗

No numbers read from the abstract.